Doseloop Beta

Aminophylline

medication Under review

A bronchodilator medication used to treat respiratory conditions such as asthma, chronic bronchitis, and emphysema.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Research in healthy human volunteers shows that aminophylline reliably increases ventilation, tidal volume, and ventilatory responsiveness to carbon dioxide, and can enhance the performance of fatigued respiratory muscles, particularly the diaphragm. Several small randomized or crossover studies in normal subjects demonstrate improvements in diaphragmatic contractility after induced fatigue and increased neural drive to inspiratory muscles, while therapeutic doses have minimal effect on contractility of a fresh, non-fatigued diaphragm. These same studies document dose-related activation of the sympathetic nervous system, with increases in catecholamines, heart rate, blood pressure, and metabolic markers, as well as a propensity for cardiac arrhythmias at clinically relevant concentrations. The overall research consensus is that aminophylline is effective as a bronchodilator and respiratory stimulant but carries a significant risk profile, making it unsuitable as a performance or wellness supplement for healthy individuals outside controlled medical settings.

Reported Benefits

Reported Side Effects

Research (5 studies)

RCT

Aminophylline increases respiratory muscle activity during hypercapnia in humans.

Respiration • 2014 • n=7

Suzuki S, Sato M, Kohno S, et al.

RCT

Aminophylline and respiratory muscle interaction in normal humans.

American Review of Respiratory Disease • 1994 • n=7

Aliverti A, Dellacà RL, Pelosi P, et al.

RCT

Both salbutamol and aminophylline increase ventilatory response to carbon dioxide in normal subjects

British Journal of Clinical Pharmacology • 1986 • n=8

Malo JL, Cartier A, L'Archevêque J, et al.

RCT

Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular and metabolic responses in man.

British Journal of Clinical Pharmacology • 1984 • n=6

Stolk J, ten Have H, Verhoeff N, et al.

RCT

Aminophylline improves diaphragmatic contractility in normal subjects

American Review of Respiratory Disease • 1981 • n=8

Loring SH, Mead J, Wanger JS, et al.

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 5
Researched benefits 2
Side effects noted 4